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Abstract
Background:  Macular  oedema  is  a  form  of  diabetic  retinopathy  that  can  be  treated  with  pho-
tocoagulation.  The  expected  effect  of  treatment  varies,  and  may  depend  on  the  previous
characteristics  of  retinal  thickening.
Objective:  To  determine  whether  the  change  in  retinal  thickness  after  focal  photocoagulation
for diabetic  macular  oedema  varies  due  to  the  presence  of  anatomical  features  that  may  justify
a separate  assessment.
Material  and  methods: Non-experimental,  comparative,  retrospective,  longitudinal  study.  The
mean percentage  change  in  macular  volume  was  compared  in  eyes  with  diabetic  macular
oedema,  3  weeks  after  focal  photocoagulation.  The  analysis  was  stratiﬁed  according  to  the
presence of  central  and  perifoveal  temporal  thickening  (Mann--Whitney  U).  A  regression  analysis
was performed  to  identify  the  contribution  of  the  anatomical  variables  before  photocoagulation
to the  change  in  macular  volume.
Results:  A  total  of  72  eyes  were  evaluated.  The  mean  change  of  macular  volume  in  the  sample
was −0.68±3.84%.  In  the  multiple  regression  analysis,  the  changes  of  perifoveal  temporal  (beta
0.54, p  <  0.001)  and  central  ﬁeld  thickness  (beta  0.3,  p  =  0.01)  contributed  to  the  change  of  mac-
ular volume  (R  =  0.64).  Macular  volume  decreased  by  a  mean  of  −2.1±4.3%  in  eyes  with  temporal
perifoveal  thickening,  and  increased  by  0.5±2.8%  (p  =  0.007)  in  eyes  with  no  thickening.
 Please cite this article as: Garcia-Rubio YZ, Razo Blanco-Hernández DM, Lima-Gómez V. Efecto esperado del grosor retiniano después de
otocoagulación focal en edema macular diabético. Cir Cir. 2016;84:356--362.
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Conclusion:  Perifoveal  temporal  thickening  before  photocoagulation  changes  the  expected
effect of  this  therapy  on  macular  volume  in  eyes  with  focal  diabetic  macular  oedema.  It  is
recommended  to  evaluate  the  effect  separately,  and  according  to  the  perifoveal  temporal
thickness.
© 2015  Academia  Mexicana  de  Cirug´ıa  A.C.  Published  by  Masson  Doyma  Me´xico  S.A.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Efecto  esperado  del  grosor  retiniano  después  de  fotocoagulación  focal  en  edema
macular  diabético
Resumen
Antecedentes:  El  edema  macular  es  una  forma  de  retinopatía  diabética  que  puede  tratarse  con
fotocoagulación.  El  efecto  esperado  del  tratamiento  varía,  y  podría  depender  de  las  caracterís-
ticas previas  del  engrosamiento  retiniano.
Objetivo:  Determinar  si  la  modiﬁcación  del  grosor  retiniano  después  de  la  fotocoagulación  focal
en edema  macular  diabético  varía  por  la  presencia  de  características  anatómicas  que  justiﬁquen
una evaluación  por  separado.
Material  y  métodos: Estudio  observacional,  comparativo,  retrospectivo  y  longitudinal.  Se  com-
paró el  promedio  de  cambio  porcentual  de  volumen  macular,  3  semanas  después  de  la
fotocoagulación  focal  en  ojos  con  edema  macular  diabético;  el  análisis  se  estratiﬁcó  conforme
a la  presencia  de  engrosamiento  central  y  temporal  perifoveal  (U  de  Mann-Whitney).  Se  realizó
un análisis  de  regresión  para  identiﬁcar  la  contribución  de  las  variables  anatómicas  al  cambio
de volumen  macular.
Resultados:  Se  evaluaron  72  ojos.  El  cambio  del  volumen  macular  en  la  muestra  fue
−0.68±3.84%. En  la  regresión  múltiple,  los  cambios  del  grosor  temporal  perifoveal  (ß  0.54;
p <  0.001)  y  del  grosor  del  campo  central  (ß  0.3;  p  =  0.01)  contribuyeron  al  cambio  del  volu-
men macular  (R  =  0.64).  El  volumen  macular  disminuyó  en  promedio  −2.1±4.3%  en  ojos  con
engrosamiento  temporal  perifoveal  y  aumentó  0.5±2.8%  (p  =  0.007)  en  ojos  sin  él.
Conclusión:  El  engrosamiento  temporal  perifoveal  previo  a  la  fotocoagulación  modiﬁcó  signi-
ﬁcativamente  el  efecto  esperado  de  este  tratamiento  sobre  el  volumen  macular,  en  ojos  con
edema macular  diabético  focal.  Se  recomienda  evaluar  el  efecto  por  separado,  de  acuerdo  con
el grosor  temporal  perifoveal.
© 2015  Academia  Mexicana  de  Cirug´ıa  A.C.  Publicado  por  Masson  Doyma  Me´xico  S.A.  Este  es  un
art´ıculo Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Diabetic  retinopathy  is  one  of  the  main  causes  of  blind-
ness  in  people  of  the  productive  age  group  in  developing
countries.  One  of  its  complications  is  macular  oedema,1
which  is  a  thickening  of  the  retina  in  the  macula  caused  by
mechanisms  including:  thickening  of  the  baseline  capillary
membrane,  loss  of  pericytes,  formation  of  microaneurisms
and  the  resulting  accumulation  of  intra-retinal  ﬂuid.2
Optical  coherence  tomography  is  a  non-invasive  imag-
ing  technique  which  uses  low  coherence  interferometry3
to  provide  high-resolution  cross-sectional  images  of  the
microstructure  of  the  retina.4 Optical  coherence  tomo-
graphy  is  used  extensively  for  the  follow-up  of  posterior
segment  diseases,5 including  identiﬁcation  and  monitoring
of  diabetic  macular  oedema,  as  it  is  able  to  quantitatively
and  reproducibly  measures  the  thickness  of  the  retina.6
Treatment  for  diabetic  macular  oedema  with  focal  angi-
ographic  ﬁltration  is  focal  photocoagulation,  which  has
w
e
broven  to  be  effective  in  reducing  the  risk  of  moderate  visual
oss  from  8%  to  5%  after  one  year,  and  from  24%  to  12%  three
ears  after  the  procedure.7
Although  optical  coherence  tomography  quantiﬁes  the
agnitude  of  changes  after  photocoagulation  in  our  sam-
le  the  anatomical  response  was  not  characterised  after
his  treatment.  In  the  North  American  population,  Krzysto-
ik  et  al.8 identiﬁed  that  changes  over  17%  in  the  thickness
f  the  central  point,  of  11%  in  the  central  ﬁeld  and  of  3%  in
acular  volume  were  more  likely  to  represent  a  real  change
han  variability  of  measurement.
The  reference  values  of  retina  thickness  in  our  sample
re  lower9 than  those  used  by  Krzystolik  et  al.8 To  detect
typical  responses  in  patients  with  macular  oedema  in  our
tudy  it  was  required  that  the  expected  anatomical  changes
ere  identiﬁed  after  focal  photocoagulation.
Even  in  those  studies  which  have  their  own  sample  refer-
nce,  response  to  photocoagulation  ﬂuctuates.  This  could
e  due  to  the  characteristics  of  the  thickening  prior  to
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reatment.  These  characteristics  have  not  been  assessed
nd  up  until  now  it  has  only  been  determined  that  macu-
ar  volume  is  the  most  solid  variable,  since  it  depends  less
n  the  operator.10 One  variable  which  requires  assessing  is
he  perifoveal  temporal  thickening,  since  the  eyes  which
resent  with  it  have  a  higher  macular  volume  prior  to  the
reatment,11 and  greater  reduction  of  macular  volume  after
t.12
A  study  was  conducted  to  determine  the  expected  effect
f  focal  photocoagulation  on  the  macular  volume,  3  weeks
fter  the  procedure  in  patients  with  diabetic  macular
edema  and  to  determine  whether  the  change  in  several
natomic  variables  prior  to  treatment  signiﬁcantly  modiﬁed
his  effect.
aterial and methods
n  observational,  comparative,  retrospective  and  longitudi-
al  study  was  conducted.  The  target  population  were  type
 diabetic  patients  with  diabetic  retinopathy  and  clinically
igniﬁcant  macular  oedema,  treated  with  focal  photocoag-
lation,  from  the  federal  district  and  its  metropolitan  area.
he  accessible  sample  were  patients  treated  by  the  Oph-
halmology  Service  of  the  general  hospital,  between  26th
arch  2008  and  5th  November  2013.  The  study  was  autho-
ised  by  the  research  and  ethics  in  research  commissions  of
he  hospital  where  the  study  took  place.
The  eyes  of  diabetic  type  2  patients  of  any  gender  and
ge  were  included  in  the  study,  with  any  grade  of  diabetic
etinopathy,  diagnosed  with  clinically  signiﬁcant  macular
edema,  focal  angiographic  ﬁltration,  spongiform  retinal
hickening,  which  had  been  treated  with  focal  photocoagu-
ation  and  which  had  been  recorded  as  having  had  a  better
orrected  visual  acuity  and  a  fast  macular  mapping  of  optical
oherence  tomography  (Equipo  Stratus,  Carl  Zeiss  Meditec,
nc.,  Dublin,  California,  U.S.A.  software  version  4.01),  on
he  day  of  photocoagulation  and  3  weeks  afterwards.
The  following  patients  were  excluded  from  the  sample:
hose  with  any  other  disease  which  reduced  their  vision,  or
here  there  was  posterior  thickening  of  vitreous  humour,
hose  who  had  received  previous  macular  treatment  and
ho  had  developed  any  other  retinal  disease  between  the
ay  of  photocoagulation  and  the  follow-up  consultancy  after
 weeks.
For every  patient  age,  gender,  time  of  evolution  and
reatment  of  diabetes  was  recorded.  Tests  were  carried
ut  to  see  if  they  suffered  from  systemic  arterial  hyperten-
ion,  fasting  blood  sugar,  glycated  haemoglobin,  total  serum
holesterol,  and  serum  triglycerides.  The  visual  acuity  best
orrected  under  refraction  measured  in  decimal  equivalent,
s  well  as  the  thickness  of  the  central  point,  the  central
eld,  the  perifoveal  temporal  thickening  and  the  macular
olume  were  recorded  (measured  using  fast  macular  thick-
ess  mapping),  on  the  day  of  treatment  and  3  weeks  after
his.  Standard  deviation  of  the  thickness  of  the  central  point
f  over  10%  was  considered  to  be  a  measurement  error  of
he  fast  macular  mapping.The  outcome  variable  was  the  percentage  change  of  mac-
lar  volume.  To  calculate  this  we  divided  the  difference
etween  the  value  relating  to  3  weeks  after  treatment  and
he  value  of  the  day  of  the  procedure,  and  the  value  of
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he  day  of  the  procedure  and  multiplied  by  100.  This  was  a
ontinuous  quantitative  variable  measured  as  a percentage.
The  following  predictors  were  considered  as  variables:
educed  visual  acuity  (<0.5),13 thickened  central  point
thickness  of  the  central  point  >187.4  m),  thickening  of  the
entral  ﬁeld  (thickness  of  the  central  ﬁeld  >212.5  m)  peri-
oveal  temporal  thickening  (thickness  of  ﬁeld  7  of  the  rapid
acular  mapping  >259.4  m),9 before  treatment.  Secondary
ariables  considered  the  percentage  change  averages  of
isual  acuity,  of  the  central  ﬁeld  thickness,  the  central  point
hickness  and  the  perifoveal  temporal  thickening.
The  sample  was  stratiﬁed  in  accordance  with  each  one  of
he  predictor  variables.  In  each  stratum  the  average  of  the
ercentage  change  of  the  macular  volume  was  compared  to
he  secondary  variables  using  the  Mann--Whitney  U  test.  In
ddition  to  this  the  contribution  of  the  secondary  variables
o  the  percentage  change  in  macular  volume  was  identiﬁed
sing  linear  regression  analysis.  The  information  was  stored
nd  analysed  with  version  21  of  the  SPSS  programme  for  Win-
ows.  P  <  0.05  was  considered  to  be  statistically  signiﬁcant.
esults
2  eyes  of  47  patients  were  assessed,  with  an  average
ge  of  57.9  years  (standard  deviation  [SD]  ±  8.9);  37  eyes
ere  female  (51.4%),  duration  of  diabetes  was  on  average
5.2  (SD  ±  6.2)  years.  Twenty  six  eyes  belonged  to  patients
ho  received  insulin  (36.1%)  and  the  other  patients  were
reated  with  oral  hypoglycaemic  agents;  38  eyes  belonged
o  patients  with  hypertension  (52.8%).
The  average  fasting  blood  sugar  level  was
38.3±41.1  mg/dl,  glycated  haemoglobin  8.4±1.7%,
otal  cholesterol  225.3±70.6  mg/dl  and  triglycerides
20.0±142.8  mg/dl.  The  degree  of  diabetic  retinopathy
as  mild  non  proliferative  in  13  eyes  (18.1%),  moderate
on  proliferative  in  35  (48.6%),  severe  non  proliferative
n  4  (5.6%),  and  proliferative  in  20  (27.8%);  oedema  was
onofocal  in  52  eyes  (72.2%).
Visual  acuity  prior  to  treatment  was  0.03  to  1.00  (aver-
ge  0.57,  SD  ±  0.29),  thickness  of  central  point  from  107  to
49  m  (185.1±43.4),  thickness  of  central  ﬁeld  from  146  to
57  m  (214.2±37.5),  perifoveal  temporal  thickening  from
13  to  485  m  (267.6±46.3)  and  macular  volume  from  6.24
o  11.17  mm3 (7.79±0.85).
Three  weeks  after  treatment,  the  level  of  visual  acuity
as  between  0.01  and  1  (0.58±0.3),  thickness  of  cen-
ral  point  between  119  and  489  m  (188.5±53.1),  thickness
f  central  ﬁeld  between  153  and  445  m  (216.7±41.0),
erifoveal  temporal  thickening  between  211  and  360  m
259.2±0.2)  and  macular  volume  between  6.39  and
0.48  mm3 (7.72±0.75).
The  averages  of  percentage  change  of  the  variables  is
hown  in  Table  1.
isual  acuityisual  acuity  was  <0.5  in  28  eyes  (38.9%)  and  ≥  0.5  in  44
61.1%).  The  eyes  with  visual  acuity  <0.5  had  higher  change
verages  in  visual  acuity  (18.87  vs.  −3.42%;  P  =  0.03),  peri-
oveal  temporal  thickening  (−4.90  vs.  −0.55%;  P  =  0.01)  and
Expected  effect  of  retinal  thickness  after  focal  photocoagulation
Table  1  Averages  of  percentage  change  in  the  sample
(n =  72).
Variable Average SD  −3  SD  +3  SD
CPT  2.51  15.39  −43.66  48.68
CFT 1.52  9.26  −26.26  29.3
PTT −2.25  7.17  −23.76  19.26
Volume −0.68 3.84  −12.2  10.84
VA 5.24 44.35 −127.81  138.29
e
i
T
A
t
c
c
P
(
c
u
t
c
S
e
a
b
m
t
t
(
t
a
t
i
t
The  expected  effect  of  focal  photocoagulation  on  mac-VA: visual acuity; CFT: Central ﬁeld thickness; CPT: central point
thickness; PTT: perifoveal temporal thickening.
macular  volume  (−2.21  vs.  0.28%;  P  =  0.01,  Table  2).  The
remaining  variables  showed  no  differences.
Thickness  of  central  point
The  central  point  had  thickened  in  28  eyes  (38.9%)  and  not  in
44  (61.1%).  The  central  point  thickness  and  macular  volume
averages  rose  in  the  eyes  with  a  thickened  central  point,  and
fell  in  the  eyes  without  it  (P  =  0.01  and  0.001  respectively);
the  average  reduction  of  the  perifoveal  temporal  thickening
was  greater  in  the  eyes  with  a  thickened  central  point  (−5.2
vs.  −0.36;  P  =  0.02)  (Table  3).
Thickness  of  central  ﬁeld
Twenty  eight  eyes  presented  with  thickening  of  the  central
ﬁeld  (38.9%)  and  44  did  not  (61.1%).  The  average  reduc-
tion  of  the  perifoveal  temporal  thickening  was  greater  in
eyes  with  a  thickening  of  the  central  ﬁeld  (−5.3±8.9%
vs.  −0.3±5.0%;  P  =  0.004);  the  macular  volume  fell  in  the
u
w
i
Table  2  Averages  of  percentage  change,  stratiﬁed  by  initial  visua
Variable  ≥0.5  (n  =  44)  
Average SD  −3  SD  +3  SD
CPT  5.10  9.97  −24.81  35.01
CFT 3.05  6.50  −16.45  22.55
PTT −0.55  6.43  −19.84  18.74
Volume 0.28  3.41  −9.95  10.51
VA −3.42  32.67  −101.43  94.59
VA: visual acuity; CFT: Central ﬁeld thickness; CPT: central point thickn
Table  3  Averages  of  percentage  change,  stratiﬁed  by  initial  cent
Variable  Normal  (n  =  44)  
Average  SD  −3  SD.  +3  SD
CPT  5.00  10.96  −27.88  37.8
CFT 3.58  6.59  −16.19  23.3
PTT −0.36  5.16  −15.84  15.1
Volume 0.66  2.99  −8.31  9.6
VA 6.99  44.81  −127.44  141.4
VA: visual acuity; CFT: Central ﬁeld thickness; CPT: central point thickn 359
yes  with  thickening  of  the  central  ﬁeld  (−2.3±4.5%),  and
ncreased  in  the  eyes  without  it  (0.4±2.9%;  P  =  0.008).
emporal  perifoveal  thickness
 total  of  34  eyes  presented  with  perifoveal  temporal
hickening  (47.2%)  and  38  did  not  (52.8%).  The  eyes  with
on  perifoveal  temporal  thickening  had  higher  averages  of
hange  in  perofoveal  temporal  thickening  (−6.26  vs.  1.34%;
 <  0.001)  and  macular  volume  (−2.10  vs.  0.57%;  P  =  0.007)
Table  4).
In the  multiple  regression  analysis  the  variables  which
ontributed  to  the  percentage  changes  of  the  macular  vol-
me  (R  =  0.64)  were  the  percentage  change  in  the  perifoveal
emporal  thickening  (ß  0.54;  P  <  0.001)  and  the  percentage
hange  of  the  thickness  of  the  central  ﬁeld  (ß  0.3;  P =  0.01).
tratiﬁcation  consistent  with  the  perifoveal  temporal  thick-
ning  identiﬁed  the  most  signiﬁcant  difference  of  volume,
nd  was  therefore  considered  for  the  regression  analysis.
In  patients  with  perifoveal  temporal  thickening  the  varia-
les  which  contributed  to  the  percentage  changes  of  the
acular  volume  (R  =  0.60)  were  the  percentage  change  of
he  perifoveal  temporal  thickening  (ß  0.44;  P =  0.009)  and
he  percentage  changes  of  the  thickness  of  the  central  ﬁeld
ß  0.32;  P  =  0.04).  In  patients  without  perifoveal  temporal
hickening  the  variables  which  contributed  to  the  percent-
ge  modiﬁcation  of  the  macular  volume  (R  =  0.49)  were  also
he  percentage  change  of  the  perifoveal  temporal  thicken-
ng  (ß  0.55;  P  <  0.001)  and  the  percentage  changes  of  the
hickness  of  the  central  ﬁeld  (ß  0.42;  P  =  0.003).lar  volume  in  eyes  with  no  perifoveal  temporal  thickening
as  an  increase  of  0.57%,  whilst  in  that  of  eyes  with  per-
foveal  temporal  thickening  it  was  a  reduction  of  −2.11%
l  acuity.
<0.5  (n  =  28)
 Average  SD  −3  SD  +3  SD
 −1.54  20.90  −64.24  61.16
 −0.89  12.18  −37.43  35.65
 −4.90  7.57  −27.61  17.81
 −2.21  4.04  −14.33  9.91
 18.87  56.19  −149.7  187.44
ess; PTT: perifoveal temporal thickening.
ral  point  thickness.
Thickness  (n  =  28)
 Average  SD  −3  SD  +3  SD
8  −1.39  20.15  −61.84  59.06
5  −1.72  11.77  −37.03  33.59
2  −5.20  8.82  −31.66  21.26
3  −2.82  4.11  −15.15  9.51
2  2.49  44.30  −130.41  135.39
ess; PTT: perifoveal temporal thickening.
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Table  4  Averages  of  percentage  change,  stratiﬁed  by  perifoveal  temporal  sector  thickness.
Variable  Normal  (n  =  38)  Thickening  (n  =  34)
Average  SD  −3  SD  +3  SD  Average  SD  −3  SD  +3  SD
CPT  2.47  14.55  −41.18  46.12  2.56  16.50  −46.94  52.06
CFT 2.35  7.87  −21.26  25.96  0.58  10.65  −31.37  32.53
PTT 1.34  3.96  −10.54  13.22  −6.26  7.83  −29.75  17.23
Volume 0.57 2.86 −8.01 9.15 −2.10  4.32  −15.06  10.86
VA 8.11 46.28 −130.73 146.95 2.03  42.56  −125.65  129.71
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pVA: visual acuity; CFT: Central ﬁeld thickness; CPT: central point 
P  =  0.003).  The  range  of  percentage  change  of  the  macu-
ar  volume  was  −8.01  to  9.1%  in  eyes  without  perifoveal
emporal  thickening  and  of  −15  to  10.8%  in  eyes  with  it
Fig.  1).
iscussion
he  expected  effect  of  the  percentage  changes  for  anatom-
cal  variables  was  highly  disperse  because  elements  from
ifference  types  of  people  overlapped  in  the  sample.  The
ariables  which  changed  the  expected  effect  when  they
ere  found  to  have  changed  prior  to  treatment  were  per-
foveal  temporal  thickening  and  thickening  of  the  central
eld.
The  average  percentage  change  of  macular  volume  was
lmost  6  times  lower  in  eyes  with  thickening  of  the  central
eld  than  in  eyes  without  it.  Furthermore,  this  corresponded
o  a  reduction  in  eyes  with  this  thickening  and  an  increase
n  eyes  without  it.  The  same  pattern  was  identiﬁed  in  eyes
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igure  1  Distribution  of  the  percentage  change  of  the  macular  vo
rior to  photocoagulation.ness; PTT: perifoveal temporal thickening.
ith  perifoveal  temporal  thickening  where  the  average  per-
entage  change  of  macular  volume  was  4  times  higher  than
n  eyes  without  it.
When  there  was  thickening  in  either  of  the  2  ﬁelds  (cen-
ral  or  temporal  perifoveal)  the  average  of  the  percentage
hange  in  macular  volume  was  statistically  lower  than  that
f  the  eyes  which  did  not  present  it.  Regression  analy-
is  showed  that  both  variables  signiﬁcantly  contributed  to
he  percentage  change  of  the  macular  volume,  primarily
he  change  in  perifoveal  temporal  thickening.  Even  when
tratiﬁcation  by  other  variables  also  modiﬁed  the  expected
ffect  of  photocoagulation  over  volume,  regression  analy-
is  showed  that  these  changes  were  mainly  linked  to  the
erifoveal  temporal  thickening.
Regarding  the  standard  published  by  Krzystolik  et  al.8 it
as  noted  that  only  15.3%  of  the  sample  had  a change  >17%n  central  point  thickness  after  treatment  and  only  11.1%
ad  a  central  ﬁeld  change  >11%.  With  regards  to  macular
olume,  there  was  a  reduction  above  3%  in  27.8%  of  the  eyes
nd  an  increase  above  3%  in  15.3%.
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1Expected  effect  of  retinal  thickness  after  focal  photocoagul
Macular  volume  is  the  most  solid  variable  among  those
measured  by  fast  macular  mapping;  it  does  not  depend  on
the  operator,10 and  was  therefore  selected  to  carry  out  the
regression  analysis.  The  results  of  the  study  indicate  that  the
expected  effect  of  focal  photocoagulation  should  be  sepa-
rately  assessed,  in  patients  and  with  and  without  thickening
of  the  perifoveal  temporal  sector.
It  was  not  expected  that  the  change  in  the  perifoveal
temporal  thickening  would  contribute  more  to  the  change
in  macular  volume  than  the  change  in  the  thickness  of  the
central  ﬁeld,  to  which  a  prognostic  value  was  assigned  in
longitudinal  studies.14 It  is  notable  that  this  greater  contri-
bution  will  also  present  in  the  eyes  without  perifoveal
temporal  thickening  prior  to  treatment.
Holm  et  al.15 put  forward  that  the  perifoveal  temporal
sector  had  greater  electric  activity  than  the  nasal  sector.
These  characteristics  could  explain  the  better  response  to
the  photocoagulation  in  eyes  without  thickening  in  this  area,
but  up  until  that  time  it  is  unknown  why  the  reduction  in
the  thickness  in  this  ﬁeld  contributes  to  that  of  the  macular
volume.
In  a  study  on  diffuse  macular  oedema  treated  with
grid  laser  photocoagulation,  Vemala  et  al.16 identiﬁed  that
response  was  better  when  treatment  was  applied  in  the
lower  sector,  and  was  worse  when  it  was  applied  in  the
upper  and  nasal  parafoveal  sectors  and  the  perifoveal  tem-
poral  sector.  This  study  showed  that  the  best  anatomical
response  to  photocoagulation  could  be  due  to  not  having
treated  the  papillary-macular  beam,  to  different  regional
characteristics  of  the  haematorretinian  barrier  or  to  varia-
tions  in  microcirculation.  The  ﬁrst  explanation  could  justify
a  poorer  result  in  the  eyes  with  nasal  compromise,  but  not
in  the  eyes  with  perifoveal  temporal  thickening  which  does
not  form  part  of  the  papillary-  macular  beam.
Sander  et  al.17 described  that,  in  diffuse  oedema,  hydro-
static  pressure,  osmotic  pressure  and  the  aquaporins  affect
retinal  thickness  and  with  the  additional  tissue  damage
could  be  the  explanation  for  the  lack  of  regularisation
of  retinal  thickness  following  treatment.  These  conditions
do  not  present  in  focal  oedema,  where  when  the  ﬂow
is  interrupted,  the  interstitial  ﬂuid  is  removed  through
the  competent  capillary  vessels  and  pigment  epithelium
pumping.18 These  2  mechanisms  should  be  assessed  specif-
ically  to  identify  why  the  change  of  perifoveal  temporal
thickening  signiﬁcantly  contributes  to  the  change  in  macular
volume.
The  ﬁndings  from  this  study  could  not  be  applied  in  eyes
with  diffuse,  cystoids  or  ischaemic  oedema.  The  study  was
not  designed  to  determine  the  impact  of  the  reduction  in
volume  regarding  visual  function,  which  requires  additional
assessment.
Due  to  the  modiﬁcation  of  the  expected  effect  associated
with  perifoveal  temporal  thickening,  it  was  recommended
that  separate  evaluation  be  made  of  response  to  photoco-
agulation  in  eyes  with  and  without  these  characteristics,  to
reduce  the  changeability  of  the  outcome.Conclusion
Perifoveal  temporal  thickening  prior  to  photocoagulation
signiﬁcantly  modiﬁed  the  expected  effect  of  this  treatment
1 361
n  macular  volume,  in  eyes  with  focal  diabetic  macular
edema.
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